Correlation of Pseudomonas aeruginosa virulence factors from clinical and environmental isolates with pathogenicity in the neutropenic mouse

Canadian Journal of Microbiology

Volumn 43, Issue 6, 1997, Pages 541-551

  Woods, D E ^a   Lam, J S ^b   Paranchych, W ^c   Speert, D P ^d   Campbell, M ^d   Godfrey, A J ^e  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e HEALTH CANADA   (Canada)

Author keywords

Clinical strains; Environmental strains; Exoenzyme S; Exotoxins; Virulence

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYCLOPHOSPHAMIDE; DISULFIDE; DNA; ELASTASE; ENZYME; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHOLIPASE C; PROTEINASE; TOXIN;

ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; BACTERIOPHAGE; BACTERIUM ADHERENCE; BACTERIUM PILUS; CONTROLLED STUDY; ENVIRONMENT; ENZYME ACTIVITY; GRAM NEGATIVE INFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LD 50; MALE; MOUSE; NEUTROPENIA; NONHUMAN; PATHOGENICITY; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PSEUDOMONAS AERUGINOSA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEROTYPE;

ANIMALIA; BACTERIA (MICROORGANISMS); NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0030835820     PISSN: 00084166     EISSN: None     Source Type: Journal    
DOI: 10.1139/m97-077     Document Type: Article

References (53)

1. Allefs, J.J.H.M., Salentijn, E.M.J., Krens, F.A., and Rouwendal, G.J.A. 1990. Optimization of non-radioactive Southern blot hybridization: single copy detection and reuse of blots. Nucleic Acids Res. 18: 3099-3100.
2. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., and Struhl, K. (Editors). 1989. Short protocols in molecular biology. Green Publishing Associates & Wiley-Interscience, New York.
3. Balteh, A.L., Griffin, P.E., and Hammer, M. 1979. Pseudomonas aeruginosa bacteremia: relationship of bacterial enzyme production and pyocine types with clinical prognosis in 100 patients. J. Lab. Clin. Med. 93: 600-606.
4. Berka, R.M., and Vasil, M.L. 1982. Phospholipase C (heat-labile hemolysin) of Pseudomonas aeruginosa: purification and preliminary characterization. J. Lab. Clin. Med. 93: 600-606.
5. Bjorn, M.J., Pavlovskis, O.R., Thompson, M.R., and Iglewski, B.H. 1979. Production of exoenzyme S during Pseudomonas aeruginosa infections of burned mice. Infect. Immun. 24: 837-842.
6. Bradley, D.E. 1973. The absorption of the Pseudomonas aeruginosa filamentous bacteriophage Pf to its host. Can. J. Microbiol. 19: 623-631.
7. Bradley, D.E., and Pitt, T.L. 1974. Pilus dependence of four Pseudomonas aeruginosa bacteriophages with non-contractile tails. J. Gen. Virol. 24: 1-15.
8. Chi, E., Mehl, T., Nunn, D., and Lory, S. 1991. Interaction of Pseudomonas aeruginosa with A549 pneumocyte cells. Infect. Immun. 59: 822-828.
9. Chung, D.W., and Collier, R.J. 1977. Enzymatically active peptide from the adenosine diphosphate-ribosylating toxin of Pseudomonas aeruginosa. Infect. Immun. 16: 832-841.
10. Cross, A.S., Sadoff, J.C., Iglewski, B.H., and Sokol, P.A. 1980. Evidence for the role of toxin A in the pathogenesis of infection with Pseudomonas aeruginosa. J. Infect. Dis. 142: 538-546.
11. Cryz, S.J., Jr., Furer, E., and Germanier, R. 1983. Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice. Infect. Immun. 39: 1067-1071.
12. Dasgupta, T., and Lam, J.S. 1995. Identification of rfbA involved in B-band lipopolysaccharide in Pseudomonas aeruginosa serotype O5. Infect. Immun. 63: 1674-1680.
13. Döring, G., Pfestorf, M., Botzenhart, K., and Abdullah, M.A. 1988. Impact of proteases on iron uptake of Pseudomonas aeruginosa pyoverdin from transferrin and lactoferrin. Infect. Immun. 56: 291-293.
14. Dubray, G., and Bezard, G. 1982. A highly sensitive periodic acid - silver stain for 1,2-diol groups of glycoproteins and polysaccharides in polyacrylamide gels. Anal. Biochem. 119: 325-329.
15. Fick, R.B., Jr. 1993. Pseudomonas aeruginosa the opportunist: pathogenesis and disease. CRC Press, Boca Raton, Fla.
16. Hancock, R.E.W., Mutharia, L.M., Chan, L., Darveau, R.P., Speert, D.P., and Pier, G.B. 1983. Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, non-typable strains deficient in lipopolysaccharide O side chains. Infect. Immun. 37: 166-171.
17. Heck, L.W., Morihara, K., and Abrahamson, D.R. 1986. Degradation of soluble laminin and depletion of tissue-associated basement membrane laminin by Pseudomonas aeruginosa elastase and alkaline protease. Infect. Immun. 54: 149-153.
18. Hitchcock, P.J., and Brown, T.M. 1983. Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels. J. Bacteriol. 154: 269-277.
19. Homma, J.Y., Abe, C, Tanamoto, K., Hirao, Y., Morihara, K., Tsuzuki, H., Yanagawa, R., Honda, E., Aoi, Y., Fujimoto, Y., Goryo, M., Imazeki, N., Noda, H., Goda, A., Takeuchi, S., and Ishihara, T. 1978. Effectiveness of immunization with single and multi-component vaccines prepared from common antigen (OEP), protease and elastase toxoids of Pseudomonas aeruginosa on protection against hemorrhagic pneumonia in mink due to P. aeruginosa. Jpn. J. Exp. Med. 48: 111-133.
20. Homma, J.Y., Tanimoto, H., Holder, I.A., Hoiby, N., and Döring, G. 1991. Pseudomonas aeruginosa in human diseases. Antibiot. Chemother. (Basel), 44: 48-53.
21. Iglewski, B.H., Sadoff, J.C., Bjorn, M.J., and Maxwell, E.S. 1978. Pseudomonas aeruginosa exoenzyme S: an adenosine diphosphate ribosyltransferase distinct from toxin A. Proc. Natl. Acad. Sci. U.S.A. 75: 3211-3215.
22. Jagger, K.S., Robinson, D.L., Franz, M.N., and Warren, R.L. 1982. Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients. J. Clin. Microbiol. 15: 1054-1058.
23. Johanson, W.G., Jr., Woods, D.E., and Chaudhuri, T.R. 1979. Association of respiratory tract colonization with adherence of gram-negative bacilli to epithelial cells. J. Infect. Dis. 139: 667-673.
24. Kocharova, N.A., Knirel, Y.A., Shashkov, A.S., Kochetkov, N.K., and Pier, G.B. 1988. Structure of an extracellular cross-reactive polysaccharide from Pseudomonas aeruginosa immunotype 4. Biol. Chem. 263: 11 291 - 11 295.
25. Lam, J.S., MacDonald, L.A., Lam, M.Y.C., Duchesne, L.G.M., and Southam, G.G. 1987a. Production and characterization of monoclonal antibodies against serotype strains of Pseudomonas aeruginosa. Infect. Immun. 55: 1051-1057.
26. Lam, J.S., MacDonald, L.A., and Lam, M.Y.C. 1987b. Production of monoclonal antibodies against serotype strains of Pseudomonas aeruginosa. Infect. Immun. 55: 2854-2856.
27. Lam, M.Y.C., McGroarty, E.J., Kropinski, A.M., MacDonald, L.A., Pedersen, S.S., Hoiby, N., and Lam, J.S. 1989. Occurrence of a common lipopolysaccharide antigen in standard and clinical strains of Pseudomonas aeruginosa. J. Clin. Microbiol. 27: 962-967.
28. Lightfoot, J., and Lam, J.S. 1993. Chromosomal mapping, expression and synthesis of lipopolysaccharide in Pseudomonas aeruginosa: a role for guanosine diphosphate (GDP); D-mannose. Mol. Microbiol. 8: 771-782.
29. Maniatis, T., Fritsch, E.F., and Sambrook, J. 1982. Molecular cloning. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
30. Paranchych, W. 1990. Molecular studies on NmePhe pili. In The bacteria. Vol. 11. Edited by V.L. Clark and B.H. Iglewski. Academic Press, New York. pp. 61-78.
31. Pasloske, B.L., Finlay, B.B., and Paranchych, W. 1985. Cloning and sequencing of the Pseudomonas aeruginosa PAK pilin gene. FEBS Lett. 183: 408-412.
32. Pasloske, B.L., Joffe, A.M., Sun, Q., Volpel, K., Paranchych, W., Eftekhar, F., and Speert, D.P. 1988. Serial isolates of Pseudomonas aeruginosa from a cystic fibrosis patient have identical pilin sequences. Infect. Immun. 56: 665-672.
33. Pavlovskis, O.R., and Wretlind, B. 1982. Pseudomonas aeruginosa toxins. In Medical microbiology. Vol. 1. Edited by C.S.F. Easmon and J. Jeljaszewicz. Academic Press Inc. (London) Ltd., London, pp. 97-128.
34. Pemberton, J.M. 1973. F116: a DNA bacteriophage specific for the pili of Pseudomonas aeruginosa strain PAO. Virology, 55: 558-560.
35. Penketh, A.R.L., Pitt, T., Roberts, D., Hodson, M.E., and Batten, J.C. 1983. The relationship of phenotype changes in Pseudomonas aeruginosa to clinical condition of patients with cystic fibrosis. Am. Rev. Respir. Dis. 127: 605-608.
36. Pitt, T.L. 1989. Lipopolysaccharide and virulence of Pseudomonas aeruginosa. Antibiot. Chemother. (Basel), 42: 1-7.
37. Quie, P.G., White, L.G., Holmes, B., and Good, R.A. 1967. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J. Clin. Invest. 46: 668-679.
38. Romling, U., Wingender, J., Muller, H., and Tümmler, B. 1994. A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl. Environ. Microbiol. 60(6): 1734-1738.
39. Sanger, F., Nicklen, S., and Coulson, A.R. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. U.S.A. 74: 5463-5467.
40. Sawyer, J.G., Martin, N.L., and Hancock, R.E.W. 1988. Interaction of macrophage cationic proteins with the outer membrane of Pseudomonas aeruginosa. Infect. Immun. 56: 693-698.
41. Siefferman, C.M., Regelmann, W.E., and Gray, B.H. 1991. Pseudomonas aeruginosa variants isolated from patients with cystic fibrosis are killed by a bactericidal protein from human polymorphonuclear leukocytes. Infect. Immun. 59: 2152-2157.
42. Sokol, P.A., Iglewski, B.H., Hager, T.A., Sadoff, J.C., Cross, A.S., McManus, A., Farber, B.F., and Iglewski, W.J. 1981. Production of exoenzyme S by clinical isolates of Pseudomonas aeruginosa. Infect. Immun. 34: 147-153.
43. Southern, E.M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98: 503-517.
44. Speert, D.P., Bond, M., Woodman, R., and Curnutte, J.T. 1994. Infection with Pseudomonas cepacia in chronic granulomatous disease: The role of nonoxidative killing by neutrophils in host defense. J. Infect. Dis. 170: 1524-1531.
45. Spitznagel, J.K., and Shafer, W.M. 1985. Neutrophil killing of bacteria by oxygen-independent mechanisms: a historical summary. Rev. Infect. Dis. 7: 398-402.
46. Titball, R.W. 1993. Bacterial phospholipase C. Microbiol. Rev. 57: 347-366.
47. Wiener-Kronish, J.P., Sakuma, T., Kudoh, I., Pittet, J.F., Frank, D., Dobbs, L., Vasil, M.L., and Matthay, M.A. 1993. Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits. J. Appl. Physiol. 75: 1661-1669.
48. Woods, D.E., and Iglewski, B.H. 1983. Toxins of Pseudomonas aeruginosa: new perspectives. Rev. Infect. Dis. 5: S715-S722.
49. Woods, D.E., and Sokol, P.A. 1985. Use of transposon mutants to assess the role of exoenzyme S in chronic pulmonary disease due to Pseudomonas aeruginosa. Eur. J. Clin. Microbiol. 4: 163-169.
50. Woods, D.E., and Sokol, P.A. 1986. Role of Pseudomonas aeruginosa extracellular enzymes in lung disease. Clin. Invest. Med. 9: 108-112.
51. Woods, D.E., and Vasil, M.L. 1994. Pathogenesis of Pseudomonas aeruginosa infections. In Pseudomonas aeruginosa: infections and treatment. Edited by A.L. Baltch and R.P. Smith. M. Dekker, New York. pp. 21-50.
52. Woods, D.E., Cryz, S.J., Friedman, R.L., and Iglewski, B.H. 1982. Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. Infect. Immun. 36: 1223-1228.
53. Woods, D.E., Schaffer, M.S., Rabin, H.R., Campbell, G.D., and Sokol, P.A. 1986. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J. Clin. Microbiol. 24: 260-264.